NCT01510704 - Phase II Dose-ranging Study of APD421 in PONV | Biotech Hunter

Enrollment

215

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions

Postoperative Nausea and Vomiting

Interventions

DRUG

APD421

DRUG

Placebo

Trial Locations (13)

Duke University Medical Center, Durham

Hautepierre Hospital, Strasbourg

Hôpital mère enfant, Bron

University Hospital, Besançon

Hôpital Huriez, Lille

University Hospital, Nancy

Hôpital FOCH, Paris

HELIOS Klinikum Aue, Aue

Charité - Universitätsmedizin, Berlin

Universität Heidelberg, Heidelberg

Klinikum Ludwigshafen, Ludwigshafen

Philipps University, Marburg

University Hospitals of Würzburg, Würzburg